Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

Summary

The primary objectives of this study to evaluate the safety, tolerability and efficacy of BGE-117 in the treatment of anemia of aging in participants ≥ 65 years of age.

Timeline

Start

2021-03-22

Primary completion

2022-04

Completion

2022-04

Outcome

Outcome not reported

Stopped (Enrollment): “The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns.”

Drugs

Indications